Keywords:
endokard, Staphylococcus aureus, Staphylococcus epidermidis, Candida, Aspergillus, exokardiogramma, elektrokardiogramma (EKG), koʻkrak qafasi rentgenogrammasi, kompyuter tomografiyasi.References
A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Iung B, Baron G, Butchart EG, et al. Eur Heart J. 2003;24:1231–1243. doi: 10.10 16/s0195-668x(03)00201-x.
Antibiotic treatment in native valve infective endocarditis. García-Borbolla R, García-Borbolla M. Infect Disord Drug Targets. 2010; 10:47–58. doi: 10.2174/187152610790410927.
Aortic valve replacement for active infective endocarditis: 5-year survival comparison of bioprostheses, homografts and mechanical prostheses. Nguyen DT, Delahaye F, Obadia JF, et al. Eur J Cardiothorac Surg. 2010;37:1025–1032. doi: 10.1016/j.ej cts.2009.11.035.
Baddour LM, Wilson WR, Bayer AS, et al: Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association. Circulation 132:1435–1486, 2015.
Cahill TJ, Baddour LM, Habib G, et al: Challenges in infective endocarditis. J Am Coll Cardiol 69 (3):325–344, 2017.
Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016 Feb 27;387(10021):882-93.
Current challenges in the management of infective endocarditis. Cuervo G, Escrihuela-Vidal F, Gudiol C, Carratalà J. Front Med (Lausanne) 2021; 8:641243. doi: 10.3389/fmed.2021.641243.
Diagnostic methods current best practices and guidelines for identification of difficult-to-culture pathogens in infective endocarditis. Houpikian P, Raoult D. Cardiol Clin. 2003; 21:207–217. doi: 10. 1016/s0733-8651(03)00028-6.
Durack DT, Beeson PB, Petersdorf RG. Experimental bacterial endocarditis. 3. Production and progress of the disease in rabbits. Br J Exp Pathol. 19 73 Apr;54(2):142-51.
Fleischauer AT, Ruhl L, Rhea S, et al. Hospitalizations for endocarditis and associated health care costs among persons with diagnosed drug dependence - North Carolina, 2010-2015 MMWR Morb Mortal Wkly Rep. 2017; 66:569–573.
Gibbons EF, Huang G, Aldea G, Koomalsingh K, Klein JW, Dhanireddy S, Harrington R. A Multidisciplinary Pathway for the Diagnosis and Treatment of Infectious Endocarditis. Crit Pathw Cardiol. 2020 Dec;19(4):187-194. doi: 10.1097/HPC. 0000000000000224. PMID: 32282401; PMCID: PMC 7664974.
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Habib G, Hoen B, Tornos P, et al. Eur Heart J. 2009;30:2369–2413.
Habib G, Derumeaux G, Avierinos JF, Casalta JP, Jamol F, Volot F, et al. The significance and limitations of Duke criteria for the diagnosis of infective endocarditis. Journal of the American College of Cardiology (J Am Coll Cardiol). 1999; 33(7): 2023–2029. DOI: 10.1016/S0735-1097(99)00116-3.
Kamde SP, Anjankar A. Pathogenesis, Diagnosis, Antimicrobial Therapy, and Management of Infective Endocarditis, and Its Complications. Cureus. 2022 Sep 15;14(9): e29182. doi: 10.7759/cureus.29 182. PMID: 36258995; PMCID: PMC9572932.
Li M, Kim JB, Sastry BKS, Chen M. Infective endocarditis. Lancet. 2024 Jul 27;404(10450):377-392. doi: 10.1016/S0140-6736(24)01098-5. PMID: 39067905.
Life-threatening complications of infective endocarditis and their management. Weinstein L. Arch Intern Med. 1986; 146:953–957.
OʻBrien L, Kerrigan SW, Kaw G, Hogan M, Penadés J, Litt D, Fitzgerald DJ, Foster TJ, Cox D. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol Microbiol. 2002 May;44(4):1033-44.
Otto CM, Nishimura RA, Bonow RO, et al: 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 77(4): e25–e197, 2021. doi: 10.1016/j.jacc.2020.11.018.
Rodbard s. Hemodynamic considerations in endocarditis. Med Sci. 1964 Jan; 15:43-9.
Veloso TR, Chaouch A, Roger T, Giddey M, Vouillamoz J, Majcherczyk P, Que YA, Rousson V, Moreillon P, Entenza JM. Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis. Infect Immun. 2013 Mar;81(3):697-703.
Verner M, Andersson R, Olaison L, Hogevik H. Endocarditis SSoIDQASGf. A 10-year survey on blood culture-negative endocarditis in Sweden: Aminoglycoside therapy is crucial for survival. Scandinavian Journal of Infectious Diseases (Scand J Infect Dis). 2008; 40(4): 279–285. DOI: 10.1080/0036554 0701642112.
Von Reyn CF, Levy BS, Arbeit RD, Friedland G, Crumpacker CS. Infectious endocarditis: An analysis based on strict case definitions. Annals of Internal Medicine (Ann Intern Med). 1981; 94(4, Part 1): 505–518. DOI: 10.7326/0003-4819-94-4-505.
Yallowitz AW, Decker LC. Infectious Endocarditis. [Updated 2023 Apr 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.
International Journal of Surgery 110:11, pages 7202-7214.
Anna Luiza Guagliardi Domingues & Laís Sette Rostirola. (2023) Endocardite Infecciosa Por Hacek: Relato De Caso. Journal of Medical Residency Review 2:1, pages e038.Crossref